SIHL Subsidiary Signs One-Year Procurement Framework Agreement with Shanghai Pharmaceuticals Holding

Reuters10-30
SIHL Subsidiary Signs One-Year Procurement Framework Agreement with Shanghai Pharmaceuticals Holding

Shanghai Industrial Holdings Limited (SIHL) announced that on 30 October 2025, its indirect non-wholly owned subsidiary, Wing Fat Printing, entered into a Procurement Framework Agreement with Shanghai Pharmaceuticals Holding. The agreement is set for a term of one year commencing from 1 January 2026. The transactions under this agreement are classified as continuing connected transactions under the Hong Kong Listing Rules and are subject to reporting, announcement, and annual review requirements, but are exempt from independent shareholders' approval. None of the Directors had a material interest in the agreement, though certain directors voluntarily abstained from voting on the relevant Board resolutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SIHL - Shanghai Industrial Holdings Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment